5-Azacytidine CAS 320-67-2 Puritas: ≥99.0% (HPLC)

Description:

Nomen: 5-Azacytidine

CAS: 320-67-2

Aspectus: Albus vel Fere Albus Crystallinus Pulvis

Puritas: ≥99.0% (HPLC)

High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Manufacturer cum High puritate et stabulo Quality
Nomen: 5-Azacytidine
CAS: 320-67-2
High Quality, Commercial Production
Supple Nucleosides intermedias

Chemical Properties:

Nomen	5-Azacytidine
Synonyma	Azacitidine;5-AzaC;Vidaza;Ladakamycin
CAS Number	320-67-2
CATTUS Number	RF-PI194
Stock Status	In Stock, Productio Ascendite ad Tons
Formulae hypotheticae	C8H12N4O5
M. Pondus	244.21
Liquescens punctum	226.0-232.0℃ (decl.)
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Alba aut fere alba Crystallina pulveris
Puritas / Analysis Methodus	≥99.0% (HPLC)
Damnum in Siccatio	≤1.0%
Residere in Ignition	≤0.50%
Metalla gravia (ut Pb)	≤20ppm
una immunditia	≤0.50%
Totalis immunditias	≤1.0%
Test Standard	Enterprise Standard
Consuetudinem	Pharmaceutical Intermedia;Synthesis organica

Sarcina & Repono:

sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, umore et peste infestatione.

commoda:

FAQ:

Applicatio:

Shanghai Ruifu Chemical Co., Ltd. est primarius fabrica et elit 5-Azacytidine (CAS: 320-67-2) cum qualitate alta.5-Azacytidine (CAS: 320-67-2) (nomen notans: Vidaza) medicamentum chemotherapy cancer anti-cancer est.Medicamentum in demethylatione et antimetabolite generatur.Azacytidine agit inhibendo incrementum et multiplicationem cellularum cancri in corpore.Medicamentum indicatur ad curationem specierum sanguinis cellularum perturbationum et medulla carcinomata ossis.Azacytidine praescribitur ut aegros tractaret cum secundariis speciebus myelodysplasticae syndrome, inter refractoria anemia quae in specie sideroblastis cincti (praesertim si transfusionem necessitatem requirit) se praebet vel e regione thrombocytopenia vel neutropenia.